Histone-deacetylase inhibitors induce the cathelicidin LL-37 in gastrointestinal cells

Molecular Immunology

Volumn 41, Issue 9, 2004, Pages 847-854

  Schauber, Jürgen ^a   Iffland, Konrad ^a   Frisch, Susanne ^a   Kudlich, Theodor ^a   Schmausser, Bernd ^a   Eck, Matthias ^a   Menzel, Thomas ^a   Gostner, Andrea ^a   Lührs, Hardi ^a   Scheppach, Wolfgang ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

Antimicrobial peptides; Butyrate; Cathelicidin LL 37; Colon; Gastric epithelium; Hepatocellular cells; Histone deacetylase inhibitors; Innate immunity

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; BUTYRIC ACID; CATHELICIDIN; CORE PROTEIN; HISTONE DEACETYLASE INHIBITOR; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; TRICHOSTATIN A;

ACETYLATION; ARTICLE; CANCER CELL; CELL LINE; COLON MUCOSA; CONTROLLED STUDY; ENZYME INHIBITION; GASTROINTESTINAL TRACT; HUMAN; HUMAN CELL; HUMAN TISSUE; INTESTINE CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

EID: 3142592392     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molimm.2004.05.005     Document Type: Article

References (39)

1. Agerberth B., et al. FALL-39, a putative human peptide antibiotic, is cysteine-free and expressed in bone marrow and testis. Proc. Natl. Acad. Sci. USA. 92(1):1995;195-199
2. Agerberth B., et al. The human antimicrobial and chemotactic peptides LL-37 and alpha-defensins are expressed by specific lymphocyte and monocyte populations. Blood. 96(9):2000;3086-3093
3. Boman H.G. Antibacterial peptides: key components needed in immunity. Cell. 65(2):1991;205-207
4. Bals R., Wilson J.M. Cathelicidins - a family of multifunctional antimicrobial peptides. Cell. Mol. Life Sci. 60:2003;711-720
5. Bals R., et al. The peptide antibiotic LL-37/hCAP-18 is expressed in epithelia of the human lung where it has broad antimicrobial activity at the airway surface. Proc. Natl. Acad. Sci. USA. 95(16):1998;9541-9546
6. Boffa L.C., Gruss R.J., Allfrey V.G. Manifold effects of sodium butyrate on nuclear function. Selective and reversible inhibition of phosphorylation of histones H1 and H2A and impaired methylation of lysine and arginine residues in nuclear protein fractions. J. Biol. Chem. 256:1981;9612-9621
7. Cowland J.B., Johnsen A.H., Borregaard N. hCAP-18, a cathelin/pro- bactenecin-like protein of human neutrophil specific granules. FEBS Lett. 368(1):1995;173-176
8. De Y., et al. LL-37, the neutrophil granule- and epithelial cell-derived cathelicidin, utilizes formyl peptide receptor-like 1 (FPRL1) as a receptor to chemoattract human peripheral blood neutrophils, monocytes, and T cells. J. Exp. Med. 192(7):2000;1069-1074
9. Frohm M., et al. The expression of the gene coding for the antibacterial peptide LL-37 is induced in human keratinocytes during inflammatory disorders. J. Biol. Chem. 272(24):1997;15258-15263
10. Frohm Nilsson M., et al. The human cationic antimicrobial protein (hCAP18), a peptide antibiotic, is widely expressed in human squamous epithelia and colocalizes with interleukin-6. Infect. Immun. 67(5):1999;2561-2566
11. Fujii S., et al. Reactivation of the silenced and imprinted alleles of ARHI is associated with increased histone H3 acetylation and decreased histone H3 lysine 9 methylation. Hum. Mol. Genet. 12(15):2003;1791-1800
12. Grunstein M. Histone acetylation in chromatin structure and transcription. Nature. 389:1997;349-352
13. Hase K., et al. Cell differentiation is a key determinant of cathelicidin LL-37/human cationic antimicrobial protein 18 expression by human colon epithelium. Infect. Immun. 70(2):2002;953-963
14. Hase K., et al. Expression of LL-37 by human gastric epithelial cells as apotential host defense mechanism against Helicobacter pylori. Gastroenterology. 125:2003;1613-1625
15. Hebbes T.R., Thorne A.W., Crane-Robinson C. A direct link between core histone acetylation and transcriptionally active chromatin. EMBO J. 7:1988;1395-1402
16. Islam D., et al. Downregulation of bactericidal peptides in enteric infections: a novel immune escape mechanism with bacterial DNA as a potential regulator. Nat. Med. 7(2):2001;180-185
17. Kouzarides T. Histone acetylases and deacetylases in cell proliferation. Curr. Opin. Genet. Dev. 9:1999;40-48
18. Kirikae T., et al. Protective effects of a human 18-kilodalton cationic antimicrobial protein (CAP18)-derived peptide against murine endotoxemia. Infect. Immun. 66(5):1998;1861-1868
19. Koczulla R., et al. An angiogenic role for the human peptide antibiotic LL-37/hCAP-18. J. Clin. Invest. 111(11):2003;1665-1672
20. Larrick J.W., et al. Human CAP18: a novel antimicrobial lipopolysaccharide-binding protein. Infect. Immun. 63(4):1995;1291-1297
21. Lührs H., et al. Modulation of HMG-N2 binding to chromatin by butyrate induced acetylation in human colon adenocarcinoma cells. Int. J. Cancer. 97:2002;567-573
22. McKnight G.S., Hager L., Palmiter R.D. Butyrate and related inhibitors of histone deacetylation block the induction of egg white genes by steroid hormones. Cell. 22(2 (Pt 2)):1980;469-477
23. Moon S.K., et al. Activation of a Src-dependent Raf-EK1/2-ER signaling pathway is required for IL-1alpha-induced upregulation of beta-defensin 2 in human middle ear epithelial cells. Biochim. Biophys. Acta. 1590:2002;41-51
24. Munshi N., et al. Acetylation of HMG I(Y) by CBP turns off IFN beta expression by disrupting the enhanceosome. Mol. Cell. 2:1998;457-467
25. Niyonsaba F., et al. Evaluation of the effects of peptide antibiotics human beta-defensins -1/-2 and LL-37 on histamine release and prostaglandin D(2) production from mast cells. Eur. J. Immunol. 31(4):2001;1066-1075
26. Nizet V., et al. Innate antimicrobial peptide protects the skin from invasive bacterial infection. Nature. 414:2001;454-457
27. Ong P.Y., et al. Endogenous antimicrobial peptides and skin infections in atopic dermatitis. N. Engl. J. Med. 347(15):2002;1151-1160
28. Putsep K., et al. Deficiency of antibacterial peptides in patients with morbus Kostmann: an observation study. Lancet. 360:2002;1144-1149
29. Rabbani G.H., et al. Short-chain fatty acids improve clinical, pathologic, and microbiologic features of experimental shigellosis. J. Infect. Dis. 179(2):1999;390-397
30. Riggs M.G., et al. n-Butyrate causes histone modification in HeLa and Friend erythroleukemia cells. Nature. 268:1977;462-464
31. Sealy L., Chalkley R. The effect of sodium butyrate on histone modification. Cell. 14:1978;115-121
32. Schauber J., et al. The expression of the cathelicidin LL-37 is modulated by short-chain fatty acids in colonocytes: Relevance of signalling pathways. Gut. 52:2003;743-751
33. Scheppach W. Effects of short chain fatty acids on gut morphology and function. Gut. 35(1 (Suppl.)):1994;S35-S38
34. Scott M.G., et al. The Human Antimicrobial Peptide LL-37 Is a Multifunctional Modulator of Innate Immune Responses. J. Immunol. 169:2002;3883-3891
35. Siavoshian S., et al. Butyrate and trichostatin A effects on the proliferation/differentiation of human intestinal epithelial cells: induction of cyclin D3 and p21 expression. Gut. 46:2000;507-514
36. Vollmers H.P., et al. Characterization of four new gastric cancer cell lines. Virchows Arch. B Cell Pathol. Incl. Mol. Pathol. 63(6):1993;335-343
37. Yamashita Y., et al. Histone deacetylase inhibitor trichostatin A induces cell-cycle arrest/apoptosis and hepatocyte differentiation in human hepatoma cells. Int. J. Cancer. 103(5):2003;572-576
38. Yoshida M., et al. Potent and specific inhibition of mammalian histoen deacetylase both in vivo and in vitro by trichostatin A. J. Biol. Chem. 265:1990;17174-17179
39. Zaiou M., Gallo R.L. Cathelicidins, essential gene-encoded mammalian antibiotics. J. Mol. Med. 80:2002;549-561